AI Optics vs Isomorphic Labs

Side-by-side comparison of features, pricing, and ratings

Analysis reviewed Live tool data as of 2026-08-23
Cross-checked through our multi-step verification ·
Saved

At a glance

DimensionAI OpticsIsomorphic Labs
FocusPortable eye screening camera + AI disease detectionAI-first drug discovery from DeepMind
PricingContact for pricingContact for pricing
Regulatory StatusFDA-cleared cameraNo FDA-cleared product
AI TechnologyOn-device AI for DR, AMD, glaucoma screeningAlphaFold-based predictive and generative models
Target UsersPrimary care, optometry, retail healthLarge pharma partners (Novartis, J&J)
Latest NewsNo recent newsSeries B (Feb 2026), J&J collaboration (Jan 2026), $600M investment (Mar 2025)

AI Optics and Isomorphic Labs serve entirely different markets—AI Optics is a point-of-care screening device for eye disease in clinical settings, while Isomorphic Labs is a pharma R&D AI platform for drug discovery. They are not direct competitors. A buyer should choose AI Optics for immediate deployable eye screening hardware/software, and Isomorphic Labs for deep pharma partnerships requiring AlphaFold-driven drug design. There is no overlap.

AI Optics
AI Optics

FDA-cleared handheld retina camera with on-device AI screening for diabetic retinopathy, AMD, and glaucoma.

Visit Website
Isomorphic Labs
Isomorphic Labs

AI-first drug discovery partner built on Nobel-winning AlphaFold.

Visit Website
Pricing
Contact Sales
Contact Sales
Plans
Popularity
1 views
7.4k views
Skill Level
Beginner-friendly
Advanced
API Available
Platforms
Mobile
Categories
🏥 Healthcare
🧬 Drug Discovery & Life Sciences
Features
FDA-cleared Sentinel Camera handheld fundus imager
Proprietary optical technology for retinal imaging
On-device AI screening for diabetic retinopathy (investigational)
On-device AI screening for age-related macular degeneration (investigational)
On-device AI screening for glaucoma (investigational)
No cloud connectivity required for AI analysis
HIPAA-compliant data handling
Portable design for point-of-care use
Designed for non-specialist providers
Suitable for primary care, optometry, retail health, long-term care
Built on Nobel-winning AlphaFold system
Generative AI molecule design via Drug Design Engine
Predictive AI models for protein-ligand interactions
Digital biology simulation at scale
End-to-end drug discovery from target ID to lead optimization
Partnership model with Novartis and Johnson & Johnson
Drug metabolism and toxicity simulation
Bioresilience framework for pandemic preparedness
US operations established in 2025
Series B funding in February 2026
Max Jaderberg appointed as President
Dr. Ben Wolf appointed as Chief Medical Officer
Interdisciplinary team of ML and drug discovery experts

What real users say: AI Optics vs Isomorphic Labs

Not marketing copy and not our opinion — a structured sweep of public discussion (reviews, forums, communities and video comments), showing what people praise and what they complain about for each tool.

AI Optics

16 mentions across 2 sources · 25% positive — critical

Hacker News, Lemmy

What users praise

  • Handheld form factor enables screening at any point of care.
  • FDA-cleared hardware inspires more confidence than purely software-only tools.
  • Targets three major eye diseases: DR, AMD, and glaucoma.
  • Designed for non-specialist use, lowering training requirements.

What frustrates them

  • No proven community satisfaction — zero user reviews or discussions exist.
  • AI diagnostic software lacks FDA clearance (Sentinel Pro).
  • Pricing is opaque, complicating cost-benefit analysis without a quote.
  • No integration details published for common EHR or practice management systems.

Researched Jul 3, 2026

Isomorphic Labs

48 mentions across 3 sources · 82% positive

Hacker News, YouTube, Lemmy

What users praise

  • Built on the Nobel-winning AlphaFold, giving it instant credibility in structural biology.
  • Drug Design Engine extends beyond structure to generative molecule design, promising novel chemistry.
  • Deep partnerships with Novartis and J&J, with potential billions in royalties.
  • Interdisciplinary team of top ML and drug discovery experts, ensuring depth of expertise.

What frustrates them

  • Not accessible to individual researchers or small biotech due to partnership model only.
  • Proprietary nature of parts of its tech limits community scrutiny and independent validation.
  • CASP16 results suggest AlphaFold 3-based models aren't always better than older methods for protein-ligand interactions.
  • No marketed drugs yet; outcomes remain uncertain with royalties tied to long timelines.

Researched Aug 18, 2026

Who should pick which

  • Primary care clinic
    Pick: AI Optics

    AI Optics provides an FDA-cleared handheld camera that screens for common eye diseases, fitting into routine checkups without specialist referrals.

  • Large pharma R&D team
    Pick: Isomorphic Labs

    Isomorphic Labs’ Drug Design Engine and AlphaFold expertise accelerate drug discovery through partnerships, ideal for large-scale programs.

  • Retail health chain
    Pick: AI Optics

    The portable, easy-to-use camera can be deployed across retail locations for preventive vision services.

  • Research institution exploring AI drug discovery
    Pick: Isomorphic Labs

    Isomorphic Labs partners with institutions for digital biology and novel molecule design, leveraging AlphaFold.

  • Long-term care facility
    Pick: AI Optics

    The device enables regular eye screening for residents, especially for diabetic retinopathy monitoring.

Frequently Asked Questions

AI Optics vs Isomorphic Labs: which should you choose?

AI Optics and Isomorphic Labs serve entirely different markets—AI Optics is a point-of-care screening device for eye disease in clinical settings, while Isomorphic Labs is a pharma R&D AI platform for drug discovery. They are not direct competitors. A buyer should choose AI Optics for immediate deployable eye screening hardware/software, and Isomorphic Labs for deep pharma partnerships requiring AlphaFold-driven drug design. There is no overlap.

Are AI Optics and Isomorphic Labs competitors?

No, they operate in completely different fields: medical devices for eye screening vs. AI drug discovery.

Does Isomorphic Labs have an FDA-cleared product?

No, Isomorphic Labs does not have any FDA-cleared devices or software; it focuses on research partnerships.

Can I buy the AI Optics Sentinel Pro software?

Sentinel Pro is currently investigational and not cleared for immediate purchase; the camera hardware is FDA-cleared.

What diseases does AI Optics screen for?

Diabetic retinopathy, age-related macular degeneration, and glaucoma.

How does Isomorphic Labs make money?

Through partnerships with pharma companies like Novartis and Johnson & Johnson, likely involving milestone payments and royalties.

What is the latest news on Isomorphic Labs?

Series B investment (Feb 2026), J&J collaboration (Jan 2026), $600M investment round (Mar 2025), and US operations establishment (Jun 2025).

Does AI Optics require a specialist to operate?

No, it is designed for non-specialist providers in primary care, optometry, retail health, and long-term care.

Which tool is better for a startup biotech?

Neither: Isomorphic Labs partners only with large pharma; AI Optics is for clinical eye screening, not drug discovery.

More AI Optics or Isomorphic Labs comparisons

Explore each tool further

Browse these categories

Still deciding? Get the weekly AI tools brief

One email a week — new tools, honest comparisons, no spam.

Last reviewed: July 3, 2026